Panaji Journal

Multiplex Assays Market size to hit USD 6.39 Bn by 2029 at a CAGR of 8.7 percent – says Maximize Market Research

 Breaking News
  • No posts were found

Multiplex Assays Market size to hit USD 6.39 Bn by 2029 at a CAGR of 8.7 percent – says Maximize Market Research

April 12
11:29 2023
Multiplex Assays Market size to hit USD 6.39 Bn by 2029 at a CAGR of 8.7 percent – says Maximize Market Research
Multiplex Assays Market
Multiplex Assays Market size was valued at USD 3.56 Bn. in 2022 and the total Multiplex Assays revenue is expected to grow at a CAGR of 8.7% from 2023 to 2029, reaching nearly USD 6.39 Bn.

Pune, 12, April 2023: The report expects the Multiplex Assays Market to grow from USD 3.56 Bn in 2022 to USD 6.39 Bn by 2029 at a CAGR of 8.7 percent over the forecast period. The report is a mixture of primary and secondary data and the domain expert has analyzed the Multiplex Assays Market from a local, global and regional point of view.

Multiplex Assays Market Report Scope and Research Methodology

The Multiplex Assays Market report provides a thorough analysis of segments and sub-segments in local, global and regional markets. The report focuses on how drivers, restraints, and macro variables affect local, global and regional Systems of Multiplex Assays markets. The report contains a comprehensive analysis of the global Multiplex Assays System market’s trends, forecasts, and monetary values. The report includes primary and secondary collection techniques with qualitative and quantitative approaches for the analysis of the Multiplex Assays market.  The Multiplex Assays market report includes aspects of the industry with key players such as market leaders, market followers and new entrants. The bottom-up approach was used in the report for Multiplex Assays market estimation. The segment-wise analysis of the Multiplex Assays Market is divided into Product & Services, Type, Technology, Application and End User.

The report provides a thorough analysis of the demand projections, market trends, and micro and macro factors Multiplex Assays market. The report covers the factors that are driving and restricting the Multiplex Assays market’s growth. The report uses analytical methodologies such as Porter’s five forces analysis and PESTLE of the Multiplex Assays Market to provide market insights. The report involves an analysis of current Multiplex Assays market trends as well as forecasts for the years. 

Multiplex Assays Market Dynamics 

The increasing prevalence of chronic disease, particularly in the geriatric population helps to increase the demand for Multiplex Assays. Multiplex Assays are significantly used in illness diagnosis, mechanism research, and the development of therapies. 

Multiplex Assays Market is driven by increasing technological advancements and innovations, increasing demand for protein multiplex assay among the End users, growing use in companion diagnostics, rising awareness regarding early disease diagnosis, growing investment in the healthcare sector and increasing research and development activities in the pharmaceutical sector for the treatment of various diseases.  During the forecast period, the market growth is expected to be hampered by the high costs of multiplex Immunoassays (MIAs).

Get a Sample Copy of the Report: https://www.maximizemarketresearch.com/request-sample/33651 

Multiplex Assays Market Regional Insights

In 2022, North America dominated the Multiplex Assays Market with the largest market share of about 42 percent and is expected to continue its dominance over the forecast period. The regional market is driven by the well-established pharmaceutical industry, high investment in research and development activities and increasing prevalence of chronic diseases such as HIV, CNS disorders, gastrointestinal disorders and others.

During the forecast period, Asia Pacific is expected to have a significant growth rate for the Multiplex Assays Market. The increase in the number of hospitals in developing countries, growing demand for healthcare infrastructure, government initiatives for the improvement of the healthcare sector and rise in medical tourism are the factors responsible for the regional growth of the market. 

Multiplex Assays Market Segmentation

By Product & Services

  • Consumables
  • Instruments
  • Software and Services

 

By Type

  • Protein Multiplex Assays
  • Planar Protein Assays
  • Bead-Based Protein Assays
  • Other Protein Assays
  • Nucleic Acid Multiplex Assays
  • Planar Nucleic Acid Assays
  • Bead-Based Nucleic Acid Assays
  • Other Nucleic Acid Assays
  • Cell-Based Multiplex Assays

 

By Technology

  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Other Technologies

 

By Application

  • Research & Development
  • Drug Discovery & Development
  • Biomarker Discovery & Validation
  • Clinical Diagnostics
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Nervous System Disorders
  • Metabolism & Endocrinology Disorders Other Diseases

 

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Other End Users

 

Multiplex Assays Market Key Players include:

  • Luminex Corporation (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Illumina, Inc (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Becton, Dickinson, and Company (United States)
  • Agilent Technologies, Inc. (United States)
  • Meso Scale Diagnostics (United States)
  • Quanterix (United States)
  • Bio-Techne Corporation (United States)
  • Promega Corporation (United States)
  • PerkinElmer, Inc. (United States)
  • Antigenix America, Inc. (United States)
  • Enzo Life Sciences, Inc. (United States)
  • Boster Biological Technology (United States)
  • Cayman Chemical Company (United States)
  • AYOXXA Biosystems GmbH |(Germany)
  • Merck KGaA (Germany)
  • Siemens Healthineers (Germany)
  • DiaSorin S.p.A. (Italy)
  • Olink (Sweden)
  • Qiagen N.V. (Netherlands)
  • Qiagen N.V. (Netherlands)
  • Abcam plc |(United Kingdom)
  • Abcam plc |(United Kingdom)
  • Randox Laboratories (United Kingdom)
  • Shimadzu Biotech (Japan)
  • Seegene (South Korea)

 

Table of Content for Global Multiplex Assays Market:

  • Global Multiplex Assays Market: Research Methodology

 

  • Global Multiplex Assays Market: Executive Summary
  • Market Overview and Definitions
  • Introduction to the Global Market
  • Summary
  • Key Findings
  • Recommendations for Investors
  • Recommendations for Market Leaders 
  • Recommendations for New Market Entry

 

  • Global Multiplex Assays Market: Competitive Analysis
  • MMR Competition Matrix
  • Market Structure by Region
  • Competitive Benchmarking of Key Players
  • Consolidation in the Market
  • M&A by region
  • Key Developments by Companies
  • Market Drivers
  • Market Restraints
  • Market Opportunities 
  • Market Challenges
  • Market Dynamics
  • PORTERS Five Forces Analysis
  • PESTLE
  • Regulatory Landscape by region
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America
  • COVID-19 Impact

 

  • Global Multiplex Assays Market Segmentation
  • Global Market, by Product & Services (2022-2029)
  • Global Market, by Type (2022-2029)
  • Global Market, by Technology (2022-2029)
  • Global Market, by Application (2022-2029)
  • Global Market, by End User (2022-2029)

 

  • Regional Global Multiplex Assays Market(2022-2029)
  • Regional Market, by Product & Services (2022-2029)
  • Regional Market, by Type (2022-2029)
  • Regional Market, by Technology (2022-2029)
  • Regional Market, by Application (2022-2029)
  • Regional Market, by End User (2022-2029)
  • Regional Market, by Country (2022-2029)

 

  • Company Profile: Key players
  • Company Overview
  • Financial Overview
  • Global Presence
  • Capacity Portfolio
  • Business Strategy 
  • Recent Developments

 

Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/33651 

Key questions answered in the Multiplex Assays Market are:

  • What is Multiplex Assays?
  • What was the Multiplex Assays market size in 2022?
  • What is the expected Multiplex Assays market size by 2029?
  • What are the different segments of the Multiplex Assays Market?
  • What are the major restraints for the growth of the Multiplex Assays Market?
  • What growth strategies are the players considering to increase their presence in Multiplex Assays?
  • What is the scope of the Multiplex Assays Market?
  • What is the growth rate of the Multiplex Assays Market?
  • Which are the factors expected to drive the Multiplex Assays market growth?
  • Which region is expected to dominate the Multiplex Assays market’s largest share?
  • What segments are covered in the Multiplex Assays Market?
  • What are the key players in the Multiplex Assays Market?
  • What are the opportunities for the Multiplex Assays Market?

 

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2022)
  • Past Pricing and price curve by region (2018 to 2022)
  • Market Size, Share, Size & Forecast by different segment | 2022−2029
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis of Product & Services, Type, Technology, Application, End User and Region
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective 
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis 
  • PORTER’s analysis 
  • Value chain and supply chain analysis 
  • Legal Aspects of Business by Region

 

Maximize Market Research Healthcare research firm, has also published the following reports:

Clinical Diagnostics MarketThe market size is expected to reach USD 115.8 Bn by 2029 at a CAGR of 6.5 percent during the forecast period. The market is driven by the increasing demand for disease detection, growing expenditure on the healthcare sector and the rising prevalence of the healthcare sector. 

Syphilis Immunoassay Diagnostics Market: The market size is expected to reach USD 659.31 Mn by 2029 at a CAGR of 3.2 percent during the forecast period. The market is driven by technological advancements in Syphilis diagnostics and increasing government initiatives encouraging early diagnosis and treatment

 

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

 

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected] 

+91 96071 95908, +91 9607365656

Media Contact
Company Name: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact Person: Geeta Yevle
Email: Send Email
Phone: +91 9607365656
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India
Website: https://www.maximizemarketresearch.com/market-report/global-multiplex-assays-market/33651/